Conexo GovU.S. federal contracts
English

Federal contract awards: NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology))

Past federal contracts, straight from USAspending.gov. Use them to price your bid, size up the competition and find the agencies that buy what you sell.

Clear filters

🔒 Pro members can search all 3 fiscal years (FY2024 to today).

Showing contracts that started in the last 12 months (first 2 pages). Register free to browse every page.

291contracts awarded
$250,324median value
$49,954 – $999,772typical range (P25–P75)
3.5average offers received
$831,063,152total obligated

Awards by fiscal year

FY2025$105,093,637 · 19
FY2026$725,969,515 · 272

Fiscal years run October to September (FY2025 = Oct 2024 – Sep 2025). The current year is still in progress.

Agencies that buy the most

Top winners

Contracts

ContractWinnerAgencyObligatedStart
HIGH-DEFINITION (HD) SPATIAL TRANSCRIPTOMIC ANALYSIS SERVICES UTILIZING VISIUM HD PLATFORM
123A9426P0056 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Urbana, IL · Offers: 1
UNIVERSITY OF ILLINOIS Department of Agriculture
Food Safety and Inspection Service
$17,679 Sep 30, 2026
Ends: Sep 29, 2027
EO 14398
36C24E26N0234 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Palo Alto, CA
PERSONALIS, INC. Department of Veterans Affairs $18,290,000 Sep 30, 2026
Ends: Sep 29, 2027
C02 SENSOR PROTOTYPE DEVELOPMENT
36C24E26P0069 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Mclean, VA · SDVOSBS · Offers: 1
RED DUKE STRATEGIES LLC Department of Veterans Affairs $1,499,888 Sep 30, 2026
Ends: Sep 29, 2027
MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
75A50126F61014 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Swiftwater, PA
SANOFI VACCINES US INC. Department of Health and Human Services
Office of Assistant Secretary for Preparedness and Response
$6,018,839
Potential value: $19,449,130
Sep 30, 2026
Ends: Sep 29, 2027
EO 14398 - RISK ASSESSMENT
75D30126P21609 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Cheshire, MA · Offers: 1
SCITOVATION, LLC Department of Health and Human Services
Centers for Disease Control and Prevention
$337,915 Sep 30, 2026
Ends: Sep 29, 2029
BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRI…
75F40126C00055 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Houston, TX · Offers: 1
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Department of Health and Human Services
Food and Drug Administration
$752,304 Sep 30, 2026
Ends: Sep 29, 2028
BAA FY26C1CP12: FDA, CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), ESTIMATION OF IN-VIVO TISSUE PROPERTIES USING CLINICAL MR THERMOMETR…
75F40126C00056 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Binghamton, NY · Offers: 1
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK Department of Health and Human Services
Food and Drug Administration
$2,456,000 Sep 30, 2026
Ends: Sep 29, 2029
TO ADVANCE THE DEVELOPMENT, EVALUATION, AND PREDICTIVE MODELING OF LEVONORGESTREL INTRAUTERINE SYSTEMS (LNG-IUSS) BY INTEGRATING ACCELERATED…
75F40126C00059 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1
UNIVERSITY OF CONNECTICUT Department of Health and Human Services
Food and Drug Administration
$511,219
Potential value: $789,844
Sep 30, 2026
Ends: Sep 29, 2028
TO CONDUCT AND DEFINE THE TECHNICAL AND PROGRAMMATIC REQUIREMENTS FOR A THREE-YEAR, MULTI-INSTITUTIONAL RESEARCH AND DEVELOPMENT EFFORT TO R…
75F40126C00060 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1
UNIVERSITY OF TEXAS AT AUSTIN Department of Health and Human Services
Food and Drug Administration
$688,145
Potential value: $990,864
Sep 30, 2026
Ends: Sep 29, 2028
THE OVERARCHING OBJECTIVE IS TO ESTABLISH A QUANTITATIVE IN VITRO IN VIVO EXTRAPOLATION FRAMEWORK CAPABLE OF PREDICTING THE INFLUENCE OF FOR…
75F40126C00063 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1
SIMULATIONS PLUS INC Department of Health and Human Services
Food and Drug Administration
$575,554
Potential value: $1,650,102
Sep 30, 2026
Ends: Dec 29, 2027
BAA CONTRACT- FY26C2AP9 ADVANCED CMC INDEX AND INTELLIGENCE PLATFORM FOR DRUG QUALITY CONTROL, SHORTAGE PREDICTION, AND STRATEGIC RESHORING
75F40126C00069 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Minneapolis, MN · Offers: 1
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC Department of Health and Human Services
Food and Drug Administration
$634,642 Sep 30, 2026
Ends: Sep 29, 2027
BAA FY26C1CP53: ADVANCING INTEGRATION OF IN VITRO TOPICAL PRODUCT CHARACTERIZATION AND SKIN PERMEATION DATA
75F40126C00071 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Offers: 1
CERTARA UK LIMITED Department of Health and Human Services
Food and Drug Administration
$352,968
Potential value: $1,083,957
Sep 30, 2026
Ends: Sep 29, 2029
EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP1 VALID APPROACHES TO INTEGRATING PATIENT SCIENCE INTO MEDICAL DEVICE STUDIES
75F40126C00081 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Durham, NC · Offers: 1
DUKE UNIVERSITY Department of Health and Human Services
Food and Drug Administration
$749,762 Sep 30, 2026
Ends: Sep 29, 2029
BAA FY26C3AP4: A CROSS-SPECIES IMMUNE ORGAN CHIP REFERENCE FRAMEWORK FOR REGULATORY EVALUATION OF VACCINE AND ANTIVIRAL MEDICAL COUNTERMEASU…
75F40126C00083 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Reno, NV · Offers: 1
BOARD OF REGENTS OF NEVADA SYSTEM OF HIGHER EDUCATION Department of Health and Human Services
Food and Drug Administration
$1,500,000
Potential value: $9,900,000
Sep 30, 2026
Ends: Sep 29, 2027
FDA BAA FY26C1CP13 3-YEAR FIRM-FIXED PRICE (FFP) CONTRACT FOR INVESTIGATING THE IMPACT OF DIASTEREOMERS AND SYNTHESIS-RELATED IMPURITIES ON …
75F40126C00087 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Storrs Mansfield, CT · Offers: 1
UNIVERSITY OF CONNECTICUT Department of Health and Human Services
Food and Drug Administration
$1,173,033
Potential value: $2,432,643
Sep 30, 2026
Ends: Sep 29, 2027
3-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1CP2, MECHANISTIC INSIGHT INTO AGGREGATION BEHAVIOR AND PREDICTIVE MODEL…
75F40126C00088 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Storrs Mansfield, CT · Offers: 1
UNIVERSITY OF CONNECTICUT Department of Health and Human Services
Food and Drug Administration
$657,981
Potential value: $1,207,750
Sep 30, 2026
Ends: Sep 29, 2028
5-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1AP28: MECHANISTIC EVALUATION OF ORAL PEPTIDE ABSORPTION USING ORGANOID-…
75F40126C00089 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Orlando, FL · Offers: 1
UNIVERSITY OF FLORIDA Department of Health and Human Services
Food and Drug Administration
$645,503
Potential value: $1,667,347
Sep 30, 2026
Ends: Sep 29, 2028
TO PROVIDE RESEARCH AND DEVELOPMENT SERVICES TO DESIGN, DEVELOP, VALIDATE, AND DELIVER AN AI-ASSISTED DIGITAL TWIN PLATFORM FOR PHARMACEUTIC…
75F40126C00093 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1
UNIVERSITY OF MASSACHUSETTS LOWELL Department of Health and Human Services
Food and Drug Administration
$456,721 Sep 30, 2026
Ends: Sep 29, 2028
BAA FY26C1CP48: A MULTI-AGENT AI SYSTEM FOR HIGH-THROUGHPUT PBPK MODELING: PREDICTING FORMULATION EFFECT ON DRUG ABSORPTION AND HUMAN PHARMA…
75F40126C00107 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Francisco, CA · Offers: 1
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Department of Health and Human Services
Food and Drug Administration
$500,000 Sep 30, 2026
Ends: Mar 29, 2028
EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE - CORE CLINICAL OUTCOME ASSESS…
75F40126C00112 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Durham, NC · Offers: 1
DUKE UNIVERSITY Department of Health and Human Services
Food and Drug Administration
$1,456,427 Sep 30, 2026
Ends: Sep 29, 2028
EO 14398 - INTEGRATING PAT TOOLS (E.G., RAMAN SPECTROSCOPY) WITH DIGITAL TWIN MODELING TO CLARIFY THE UNCERTAINTY IN DIRECT CQA CONTROL WITH…
75F40126C00156 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Lowell, MA · Offers: 1
UNIVERSITY OF MASSACHUSETTS LOWELL Department of Health and Human Services
Food and Drug Administration
$861,756 Sep 30, 2026
Ends: Sep 29, 2028
EO 14398-BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT FOR MODERNIZING OUTCOME DATA FOR OPIOID USE DISORDER (MOD-OUD)
75F40126C00158 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Boston, MA · Offers: 1
DIGITAL MEDICINE SOCIETY INC Department of Health and Human Services
Food and Drug Administration
$948,781 Sep 30, 2026
Ends: Dec 30, 2027
FIRM FIXED PRICE AWARD TOWARDS ML-POWERED, EFFICIENT AND ROBUST INFERENCE OF AVERAGE AND INDIVIDUAL TREATMENT EFFECTS FOR NOVEL CLINICAL TRI…
75F40126C00181 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1
DUKE UNIVERSITY Department of Health and Human Services
Food and Drug Administration
$1,256,810 Sep 30, 2026
Ends: Sep 29, 2030
SUNSCREEN ABSORPTION CLINICAL PHARMACOLOGY STUDY
75F40126F19004 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Webster, TX
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Department of Health and Human Services
Food and Drug Administration
$1,294,478 Sep 30, 2026
Ends: Sep 29, 2027
DDI CLINICAL PHARMACOLOGY STUDY
75F40126F19005 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Webster, TX
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Department of Health and Human Services
Food and Drug Administration
$1,592,481 Sep 30, 2026
Ends: Sep 29, 2027
Page 1 of 2Next →
See every page

Free members can browse the full list of the last 12 months of awards.

Register free

Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.